|
Volumn 51, Issue RR-3, 2002, Pages 1-31
|
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETAMIDE DERIVATIVE;
AMANTADINE;
ANTIVIRUS AGENT;
GUANIDINE DERIVATIVE;
INFLUENZA VACCINE;
OSELTAMIVIR;
PYRAN DERIVATIVE;
RIMANTADINE;
SIALIC ACID DERIVATIVE;
ZANAMIVIR;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHILD;
COST BENEFIT ANALYSIS;
ECONOMICS;
HUMAN;
IMMUNOLOGY;
INFANT;
INFLUENZA;
INFLUENZA VIRUS A;
INFLUENZA VIRUS B;
MIDDLE AGED;
PRACTICE GUIDELINE;
PRESCHOOL CHILD;
RISK FACTOR;
STANDARD;
UNITED STATES;
VACCINATION;
ACETAMIDES;
ADOLESCENT;
ADULT;
AGED;
AMANTADINE;
ANTIVIRAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
COST-BENEFIT ANALYSIS;
GUANIDINES;
HUMANS;
INFANT;
INFLUENZA A VIRUS;
INFLUENZA B VIRUS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
MIDDLE AGED;
OSELTAMIVIR;
PYRANS;
RIMANTADINE;
RISK FACTORS;
SIALIC ACIDS;
UNITED STATES;
VACCINATION;
ZANAMIVIR;
|
EID: 0037066803
PISSN: 10575987
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (387)
|
References (0)
|